A股異動 | 真視通再次強勢漲停 錄得三連板 雲視頻業務穩定增長
格隆匯2月6日丨真視通(002771.SZ)今日再次強勢漲停,錄得三連板。現報13.7元,暫成交2.42億元,最新總市值28.75億元。真視通日前接受調研時表示,春節期間應客户需求,公司為100多個客户開通雲視頻服務,數量仍在逐步提升。新開通客户中,重點保障抗擊疫情的一線需求,在線教育、學校等客户數量更多,未在完全統計範圍內。公司雲視頻客户羣體不同於阿里、騰訊,公司主要面向政府央企提供定製化開發服務,目前收入佔比不高,希望此次疫情對雲視頻業務的銷售起到促進作用。此外,公司是華為的金牌經銷商,已經和華為保持了多年的合作關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.